News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

Timothy Tramontana, MD

Timothy Tramontana, MD, medical and biochemical geneticist, Cleveland Clinic Foundation.

Articles by Timothy Tramontana, MD

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU

BySuzanne Hollander, MS, RD, LDN,Timothy Tramontana, MD

July 29th 2025

Suzanne Hollander, MS, RD, LDN; and Timothy Tramontana, MD, offer thoughts on newly FDA-approved sepiapterin for PKU.

Latest Updated Articles

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Published: July 29th 2025 | Updated:

Trending on Contemporary Pediatrics

Weekly review: CDC's updated website, roflumilast 0.3%, and more

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

© 2025 MJH Life Sciences^®

All rights reserved.